A case report of malignant pleural mesothelioma with long-term disease control after chemotherapy

Cancer. 1991 Jan 1;67(1):48-54. doi: 10.1002/1097-0142(19910101)67:1<48::aid-cncr2820670110>3.0.co;2-i.

Abstract

Long duration of responses to chemotherapy in patients with malignant pleural mesothelioma (MPM) is rare. The authors report a patient with inoperable MPM who achieved complete remission with combination chemotherapy of cyclophosphamide, doxorubicin, and cisplatin. 5-fluorouracil and mitomycin C (FM) induced another remission after recurrence of the tumor. Retreatment with FM after chemotherapy had been stopped for 20 months yielded another continuing response. The overall tumor-control time is more than 4 years. Literature reviews and the authors' results suggest that MPM may be a chemosensitive tumor in some patients. Additional evaluations of CAP, FM, and methotrexate combination regimens in this disease should be considered.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Mesothelioma / drug therapy*
  • Middle Aged
  • Mitomycin
  • Mitomycins / administration & dosage
  • Pleural Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Mitomycins
  • Mitomycin
  • Cyclophosphamide
  • Cisplatin
  • Fluorouracil